Summary
34 / 100 · Bulios Score
What speaks for it
- Out of every 100 EUR of revenue, 13 EUR is left as free cash.
- The price moves less than the market (beta 0.28).
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 6.2% a year over the last 3 years.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
- Analyst estimate
Revenue fell by 3.1% a year over 5 years. Over the last 3 years it fell by 6.2% a year. Earnings per share fell by 1.1% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 12.01%
- Raised in a row
- 3 years
You receive $0.17 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 8
- Hold 7
- Sell 5
No analyst has published a price target.
40% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
This revenue breakdown is on the way.
By region
This revenue breakdown is on the way.